Full text
2/2026
vol. 28
Original paper
Assessment of insulin therapy perception among patients with type 2 diabetes mellitus attending El-Mahsama Family Practice Center in Ismailia Governorate, Egypt
Family Medicine Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
Family and Community Medicine Department, Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia
Family Medicine & Primary Care Review 2026; 28(2): 164–170
Data publikacji online: 2026/06/22
Article file
- Arroyave F, Montaño D, Lizcano F. Diabetes mellitus is a chronic disease that can benefit from therapy with induced pluripotent stem cells. Int J Mol Sci 2020; 21(22): 8685.
- International Diabetes Federation. IDF Diabetes Atlas. 11th ed. Brussels (Belgium): International Diabetes Federation; 2025.
- World Health Organization. African region tops world in undiagnosed diabetes: WHO analysis [Internet]. WHO Regional Office for Africa [cited 14.10.2023]. Available from URL: https://www.afro.who.int/news/african-region-tops-world-undiagnosed-diabetes-who-analysis.
- ElSayed NA, Aleppo G, Aroda VR, et al. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes – 2023. Diabetes Care 2023; 46(Suppl. 1): S140–S157.
- Silver B, Ramaiya K, Andrew SB, et al. EADSG guidelines: Insulin therapy in diabetes. Diabetes Ther 2018; 9(2): 449–492, doi: 10.1007/s13300-018-0384-6.
- Holmes-Truscott E, Pouwer F, Speight J. Assessing psychological insulin resistance in type 2 diabetes: A critical comparison of measures. Curr Diab Rep 2017; 17(7): 4, doi: 10.1007/s11892-017-0873-4.
- Ahmed EM, Wahdan MM, Bayoumy EM, et al. Factors affecting opposition of insulin initiation among type 2 DM patients at Ain Shams University Hospitals. Egypt Fam Med J 2021; 5(1): 141–155.
- Cosson E, Mauchant C, Benabbad I, et al. Perceptions of insulin therapy in people with type 2 diabetes and physicians: a cross-sectional survey conducted in France. Patient Prefer Adherence 2019; 13: 251–260.
- Dawson B, Trapp RG, eds. Basic and Clinical Biostatistics. 4th ed. New York: McGraw-Hill Professional; 2004.
- El-Gilany A, El-Wehady A, El-Wasify M. Updating and validation of the socioeconomic status scale for health research in Egypt. East Mediterr Health J 2012; 18(9): 962–968.
- Standards of Care in Diabetes – 2023. Silverchair-cdn.com [07.11.2024]. Available from URL: https://rb.gy/r6dxz2.
- Snoek FJ, Skovlund SE, Pouwer F. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health Qual Life Outcomes 2007; 5: 69, doi: 10.1186/1477-7525-5-69.
- Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018; 41(12): 2669–2701.
- Hussein A, Mostafa A, Areej A, et al. The perceived barriers to insulin therapy among type 2 diabetic patients. Afr Health Sci 2019; 19(1): 185757, doi: 10.4314/ahs.v19i1.39.
- Ahmed Z, Hafez MA, Bari MA, et al. Pattern of anti-diabetic drugs prescribed in a tertiary care hospital of Bangladesh. Int J Basic Clin Pharmacol 2016; 5(1): 6–12, doi: 10.18203/2319-2003.ijbcp20160079.
- Khalil SHA, Khaled M, Zakhary R, et al. The rate of insulin use and suboptimal glycemic control among Egyptian patients with type 2 diabetes: cohort analysis of eighth wave of the International Diabetes Management Practices Study (IDMPS). Curr Diabetes Rev 2024; 20(3): e020623217590.
- Sharma N, Sharma SK, Maheshwari VD, et al. Association of low educational status with microvascular complications in type 2 diabetes: Jaipur diabetes registry. Indian J Endocrinol Metab 2015; 19(6): 775–780.
- Ikeda N, Takimoto H, Imai S, et al. Data resource profile: the Japan National Health and Nutrition Survey (NHNS). Int J Epidemiol 2015; 44(6): 1842–1849.
- Kweon S, Kim Y, Jang M, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol 2014; 43(1): 69–77.
- Zakaria N, Baskaran N, Lim WL. Perception towards insulin therapy and factors related to insulin refusal among insulin-naive type 2 diabetes mellitus patients in primary care clinics PKD Lipis. J Pharm 2021; 1(2): 70–78.
- Ghadiri-Anari A, Fazaelipoor Z, Mohammadi SM. Insulin refusal in Iranian patients with poorly controlled type 2 diabetes mellitus. Acta Med Iran 2013; 51(8): 567–571.
- Saleem A, Masood I, Khan TM. Insulin perception among insulin-naïve type 2 diabetes mellitus patients in Pakistan. Cogent Med 2016; 3(1): 1229374.
- Sabei LT, Sammud M. Attitude towards insulin therapy among patients with type 2 diabetes in Tripoli, Libya. Ibnosina J Med Biomed Sci 2015; 7(4): 127–135.
- Batais MA, Schantter P. Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with type 2 diabetes in Saudi Arabia. Prim Care Diabetes 2016; 10(6): 415–424.
- Lee KP. Psychosocial factors associated with psychological insulin resistance in primary care patients in Hong Kong. J Clin Transl Endocrinol 2015; 2(4): 157–162.
- Tan W, Asahar S, Harun N. Insulin therapy refusal among type II diabetes mellitus patients in Kubang Pasu district, Kedah, Malaysia. Singapore Med J 2015; 56(4): 224–227.
- Machinani S, Bazargan-Hejazi S, Hsia SH. Psychological insulin resistance among low-income, U.S. racial minority patients with type 2 diabetes. Prim Care Diabetes 2013; 7(1): 51–55.
- Saleem A. Challenges to access and affordability of medicines and health care in Pakistan. J Clin Pract Health Sci 2015; 1: 19–21.
- Woudenberg YJC, Lucas C, Latour C, et al. Acceptance of insulin therapy: a long shot? Psychological insulin resistance in primary care. Diabet Med 2012; 29(6): 796–802.
- Abu Hassan H, Tohid H, Mohd Amin R, et al. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration. BMC Fam Pract 2013; 14: 1–10.
Copyright: © 2026 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.